BPIRX
Price
$15.49
Change
-$0.06 (-0.39%)
Updated
Nov 12 closing price
QLENX
Price
$16.29
Change
+$0.02 (+0.12%)
Updated
Nov 12 closing price
Ad is loading...

BPIRX vs QLENX

Header iconBPIRX vs QLENX Comparison
Open Charts BPIRX vs QLENXBanner chart's image
Boston Partners Long/Short Rsrch Instl
Price$15.49
Change-$0.06 (-0.39%)
VolumeN/A
CapitalizationN/A
AQR Long-Short Equity N
Price$16.29
Change+$0.02 (+0.12%)
VolumeN/A
CapitalizationN/A
BPIRX vs QLENX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BPIRX vs. QLENX commentary
Nov 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPIRX is a Buy and QLENX is a Hold.

FUNDAMENTALS
Fundamentals
QLENX has more cash in the bank: 2.06B vs. BPIRX (622M). QLENX pays higher dividends than BPIRX: QLENX (18.52) vs BPIRX (2.17). BPIRX was incepted earlier than QLENX: BPIRX (14 years) vs QLENX (11 years). BPIRX is a more actively managed with annual turnover of: 54.00 vs. QLENX (0.00). QLENX has a lower initial minimum investment than BPIRX: QLENX (2500) vs BPIRX (100000). QLENX annual gain was more profitable for investors over the last year : 25.63 vs. BPIRX (11.35). QLENX return over 5 years is better than : 96.88 vs. BPIRX (2.00).
BPIRXQLENXBPIRX / QLENX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years11 years-
Gain YTD17.08226.67264%
Front LoadN/AN/A-
Min. Initial Investment10000025004,000%
Min. Initial Investment IRAN/AN/A-
Net Assets622M2.06B30%
Annual Yield % from dividends2.1718.5212%
Returns for 1 year11.3525.6344%
Returns for 3 years-9.2194.58-10%
Returns for 5 years2.0096.882%
Returns for 10 years7.27126.226%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZOM0.140.02
+14.38%
Zomedica Corp
EVRG63.680.40
+0.63%
Evergy
HOTH0.89N/A
-0.06%
Hoth Therapeutics
AVAL2.00-0.01
-0.50%
Grupo Aval Acciones Y Valores SA
MLYS13.38-1.54
-10.32%
Mineralys Therapeutics